Omicron: A heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies
This study investigates Omicron's enhanced ACE2 binding and antibody escape by analyzing mutations in the spike protein and their impact on binding free energies and electrostatic potentials.
Frontiers in Immunology · Jan 24, 2022Peer-reviewedGenomics